Treatment of Atraumatic Rotator Cuff Rupture in Elderly Patients (toarcriep)
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the investigators study is to compare the effect of: 1) physiotherapy 2) arthroscopic acromioplasty and debridement or 3) arthroscopic rotator cuff reconstruction and acromioplasty in the treatment of degenerative, atraumatic rotator cuff rupture.
| Condition | Intervention |
|---|---|
|
Atraumatic Rotator Cuff Rupture |
Procedure: physiotherapy Procedure: acromioplasty Procedure: acromioplasty and rotator cuff reconstruction |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Treatment of Atraumatic Rotator Cuff Rupture in Elderly Patients |
- Shoulder score by Constant and Murley [ Time Frame: 2 years ] [ Designated as safety issue: No ]Constant scoring is endorsed by SECEC/ESSSE and is the most largely used instrument measuring shoulder pain, function and strenght. This scoring system is very suited for evaluating disability caused by rotator cuff ruptures.
- Constant score [ Designated as safety issue: No ]subjective and objective shoulder score
| Estimated Enrollment: | 180 |
| Study Start Date: | February 2009 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: physiotherapy | Procedure: physiotherapy |
| Active Comparator: acromioplasty | Procedure: acromioplasty |
| Active Comparator: acromioplasty and rotator cuff reconstruction | Procedure: acromioplasty and rotator cuff reconstruction |
Detailed Description:
The study will be conducted according to the revised Declaration of Helsinki by The World Medical Association and the ICH-guidelines for good clinical trial practice. The study will be submitted for approval to the Ethics Committee of the Hospital District of Varsinais-Suomi, Finland. A written informed consent will be obtained from each patient.
This study will be conducted at three different hospitals i.e. Turku University Hospital, Tampere University Hospital (Hatanpää hospital) and Kuopio University Hospital as a multicenter study. A total of 180 patients, 60 patients at each hospital, will be included in this study. The patients are clinically examined and a routine x-ray and MRI-investigation are performed. Patients must have an atraumatic degenerative supraspinatus tendon rupture comprising less than 2/3 of the tendon insertion, i.e. 1/3 of the tendon insertion must be intact. The rupture must be documented by MRI investigation. Patients must be willing and give a written informed consent. After recruitment the patients are randomized in one of three studied treatment modalities. The randomization is made after clinical and MRI investigation by neutral attendant using sealed envelopes. 60 identical envelopes (20 per group) are made in each center.
The Constant score is used as a primary outcome measure. The Constant score is measured from each patient right before treatment intervention and at three and six months, one, two and five years after the intervention. The intervention groups are designed in a cumulative fashion: structured and standardized physiotherapy treatment proceeds gradually in all patients (groups 1,2,3), in addition to physiotherapy patients in group 2 are treated with acromioplasty, and patients in group 3 with acromioplasty and rotator cuff reconstruction.
Eligibility| Ages Eligible for Study: | 55 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- age over 55 years
- atraumatic penetrating supraspinatus tendon rupture comprising less than 2/3 of the tendon insertion and documented with MRI investigation.
- full active range of motion
- written informed consent from participating subject
Exclusion Criteria:
- age under 55 years
- existing significant malignant, haematological, endocrine, metabolic, rheumatoid or gastrointestinal disease
- cytostatic or corticosteroid medication
- glenohumeral osteoarthrosis grade III or above (X-ray evaluation with present osteophytes according to Kellgren-Lawrence classification)
- history of alcoholism, drug abuse, psychological or other emotional problems that are likely to invalidate informed consent
- previous same shoulder surgery
- a massive tendon tear involving the whole supraspinatus tendon and/or combined tear of two - three tendons ie. supraspinatus with infraspinatus or subscapularis tendon tear.
- patients denial
Contacts and Locations| Contact: Ville Äärimaa, MD, PhD | +358 (0)2 3130000 | ville.aarimaa@tyks.fi |
| Contact: Juha Kukkonen, MD | +358 (0)2 3130000 | juha.kukkonen@tyks.fi |
| Finland | |
| Kuopio University Hospital | Recruiting |
| Kuopio, Finland, 70211 | |
| Contact: Antti Joukainen, MD, PhD +358 0(17) 173311 antti.joukainen@kuh.fi | |
| Tampere University Hospital | Recruiting |
| Tampere, Finland, 33101 | |
| Contact: Janne Lehtinen, MD,PhD +358 (0)3 565713 janne.lehtinen@tampere.fi | |
| Turku University Hospital | Recruiting |
| Turku, Finland, 20701 | |
| Contact: Juha Kukkonen, MD +358 (0)2 3130000 juha.kukkonen@tyks.fi | |
| Principal Investigator: | Juha Kukkonen, MD | Turku University Hospital |
| Study Director: | Ville Äärimaa, MD, PhD | Turku University Hospital |
More Information
No publications provided
| Responsible Party: | Juha Kukkonen, MD, Turku University Hospital |
| ClinicalTrials.gov Identifier: | NCT01116518 History of Changes |
| Other Study ID Numbers: | 106/2007 |
| Study First Received: | April 29, 2010 |
| Last Updated: | November 30, 2011 |
| Health Authority: | Finland: Ethics Committee |
Additional relevant MeSH terms:
|
Rupture Wounds and Injuries |
ClinicalTrials.gov processed this record on May 23, 2013